Optic Atrophy 

  • Author: Rashmin Gandhi, MBBS, FRCS(Edin), FRCS(Glasg); Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: May 10, 2010
 

Background

Optic atrophy is the final common morphologic endpoint of any disease process that causes axon degeneration in the retinogeniculate pathway. Clinically, optic atrophy manifests as changes in the color and the structure of the optic disc associated with variable degrees of visual dysfunction. Optic atrophy is actually a misnomer; in the strict histologic definition, atrophy refers to involution of a structure resulting from prolonged disuse.

Next

Pathophysiology

The optic nerve comprises approximately 1.2 million axons that originate at the ganglion cell layer of the retina. The axons of the optic nerve are heavily myelinated by oligodendrocytes, and the axons, once damaged, do not regenerate. Thus, the optic nerve behaves more like a white matter tract rather than a true peripheral nerve.

The optic nerve is divided into the following 4 parts:

  • Intraocular part (1 mm), also known as the optic nerve head
  • Intraorbital part (25 mm)
  • Intracanalicular part (5 mm)
  • Intracranial part (10 mm)

The optic nerve head is 1 mm deep, 1.5 mm horizontally, 1.8 mm vertically at the retinal level, and a little wider posteriorly. The optic nerve head is a major transition between an area of high pressure to an area of low pressure (intracranial pressure). The optic nerve head comprises 4 types of cells, as follows: ganglion cell axons, astrocytes, capillary-associated cells, and fibroblasts. The optic nerve fibers pass through the lamina cribrosa (a sievelike structure with 200-300 holes that perforate the choroid and the sclera). These structures are shown in the image below.

Normal optic nerve histopathology. Normal optic nerve histopathology.

The optical property of normal axons of the optic disc is similar to fiber optic cable. The incident light originating from the ophthalmoscope undergoes total internal reflection through the axonal fibers and is reflected back by the capillaries on the disc surface, giving rise to the characteristic yellow-pink color of a healthy optic disc (shown in the image below). The degenerated axons do not possess this optical property, leading to the atrophic disc's pale appearance.

Healthy optic disc. Healthy optic disc.

Pial capillaries arising from the circle of Zinn-Haller supply the optic disc. These capillaries exhibit autoregulation and are not leaky. According to another theory, the loss of capillaries in optic atrophy causes the pale-appearing disc.

The Kestenbaum count is the number of capillaries observed on the optic disc. The normal count is approximately 10. In optic atrophy, the number of these capillaries reduces to less than 6; in a hyperemic disc, the count is more than 12.

Histopathologic changes in optic atrophy

  • Shrinkage or loss of both myelin and axis cylinders
  • Gliosis
  • Deepening of the physiologic cup with barring of the lamina cribrosa
  • Widening of the subarachnoid space with redundant dura
  • Widening of the pial septa
  • Severed nerve leads to bulbous axonal swellings (Cajal end bulbs); may be observed at the anterior cut end of the fibers

Classification

Optic atrophy is classified as pathologic, ophthalmoscopic, or etiologic.

Pathologic classification

Anterograde degeneration (Wallerian degeneration) is as follows:

  • In conditions with anterograde degeneration (eg, toxic retinopathy, chronic simple glaucoma), deterioration begins in the retina and proceeds toward the lateral geniculate body (ie, to the brain).
  • Axon thickness determines the rate of degeneration. Larger axons disintegrate more rapidly than smaller axons. The essential feature is swelling and degeneration of the axon terminal in the lateral geniculate body (LGB), observed as early as 24 hours. Leukocytes rarely present in Wallerian degeneration.

Retrograde degeneration is as follows:

  • In conditions with retrograde degeneration (optic nerve compression by intracranial tumor), deterioration starts from the proximal portion of the axon and proceeds toward the optic disc (ie, to the eye).
  • The time course of this degeneration is apparently independent of the distance of the injury from the ganglion cell body. Thus, damage to the retrobulbar portion of the optic nerve, the optic chiasma, or the optic tract causes pathologic and visible degeneration of the ganglion cell body simultaneously.

Trans-synaptic degeneration is as follows:

  • In trans-synaptic degeneration, a neuron on one side of a synapse degenerates as a consequence of the loss of a neuron on the other side.
  • This type of degeneration is observed in patients with occipital damage incurred either in utero or during early infancy.

Ophthalmoscopic classification

  • Primary optic atrophy (shown in the image below): In conditions with primary optic atrophy (eg, pituitary tumor, optic nerve tumor, traumatic optic neuropathy, multiple sclerosis), optic nerve fibers degenerate in an orderly manner and are replaced by columns of glial cells without alteration in the architecture of the optic nerve head. The disc is chalky white and sharply demarcated, and the retinal vessels are normal. Lamina cribrosa is well defined. Primary optic atrophy. Primary optic atrophy.
  • Secondary optic atrophy: In conditions with secondary optic atrophy (eg, papilledema, papillitis), the atrophy is secondary to papilledema (shown in the image below). Optic nerve fibers exhibit marked degeneration, with excessive proliferation of glial tissue. The architecture is lost, resulting in indistinct margins. The disc is grey or dirty grey, the margins are poorly defined, and the lamina cribrosa is obscured due to proliferating fibroglial tissue. Hyaline bodies (corpora amylacea) or drusen may be observed. Peripapillary sheathing of arteries as well as tortuous veins may be observed. Progressive contraction of visual fields may be seen as well. Optic atrophy following papilledema (secondary). Optic atrophy following papilledema (secondary).
  • Consecutive optic atrophy (shown in the image below): In consecutive optic atrophy (eg, retinitis pigmentosa, myopia, central retinal artery occlusion), the disc is waxy pale with a normal disc margin, marked attenuation of arteries, and a normal physiologic cup. Consecutive optic atrophy following panretinal phoConsecutive optic atrophy following panretinal photocoagulation (PRP).
  • Glaucomatous optic atrophy (shown in the image below): Also known as cavernous optic atrophy, marked cupping of the disc is observed in glaucomatous optic atrophy. Characteristics include vertical enlargement of cup, visibility of the laminar pores (laminar dot sign), backward bowing of the lamina cribrosa, bayoneting and nasal shifting of the retinal vessels, and peripapillary halo and atrophy. Splinter hemorrhage at the disc margin may be observed. Glaucomatous optic atrophy histopathology. Glaucomatous optic atrophy histopathology.
  • Temporal pallor: Temporal pallor may be observed in traumatic or nutritional optic neuropathy, and it is most commonly seen in patients with multiple sclerosis, particularly in those with a history of optic neuritis. The disc is pale with a clear, demarcated margin and normal vessels, and the physiologic pallor temporally is more distinctly pale.

Etiologic classification

Regardless of etiology, optic atrophy is associated with variable degrees of visual dysfunction, which may be detected by one or all of the optic nerve function tests (see Other Tests).

  • Hereditary: This is divided into congenital or infantile optic atrophy (recessive or dominant form), Behr hereditary optic atrophy (autosomal recessive), and Leber optic atrophy.
  • Consecutive atrophy: Consecutive atrophy is an ascending type of atrophy (eg, chorioretinitis, pigmentary retinal dystrophy, cerebromacular degeneration) that usually follows diseases of the choroid or the retina.
  • Circulatory atrophy: Circulatory is an ischemic optic neuropathy observed when the perfusion pressure of the ciliary body falls below the intraocular pressure. Circulatory atrophy is observed in central retinal artery occlusion, carotid artery occlusion, and cranial arteritis.
  • Metabolic atrophy is observed in disorders such as thyroid ophthalmopathy, juvenile diabetes mellitus, nutritional amblyopia, toxic amblyopia, tobacco, methyl alcohol, and drugs (eg, ethambutol, sulphonamides).
  • Demyelinating atrophy is observed in diseases such as multiple sclerosis and Devic disease.
  • Pressure or traction atrophy is observed in diseases such as glaucoma and papilledema.
  • Postinflammatory atrophy is observed in diseases such as optic neuritis, perineuritis secondary to inflammation of the meninges, and sinus and orbital cellulites.
  • Traumatic optic neuropathy: The exact pathophysiology of traumatic optic neuropathy is poorly understood, although optic nerve avulsion and transection, optic nerve sheath hematoma, and optic nerve impingement from a penetrating foreign body or bony fragment all reflect traumatic forms of optic nerve dysfunction that can lead to optic atrophy.
Previous
Next

Epidemiology

Frequency

United States

According to Tielsch et al, the prevalence of blindness attributable to optic atrophy was 0.8%.[1]

According to Munoz et al, the prevalence of visual impairment and blindness attributable to optic atrophy was 0.04% and 0.12%, respectively.[2]

Mortality/Morbidity

Optic atrophy is not a disease but a sign of many disease processes. Thus, morbidity and mortality in optic atrophy depends on the etiology.

Race

Optic atrophy is more prevalent in African Americans (0.3%) than in whites (0.05%).

Sex

There is no sexual predisposition noted.

Age

Optic atrophy is seen in any age group.

Previous
 
 
Contributor Information and Disclosures
Author

Rashmin Gandhi, MBBS, FRCS(Edin), FRCS(Glasg)  Faculty, Departments of Ocular Physiology and Neuro-ophthalmology, Elite School of Optometry; Faculty, CU Shah Ophthalmic Postgraduate Center, Consulting Staff, Department of Ophthalmology, Sankara Nethralaya Hospital

Rashmin Gandhi, MBBS, FRCS(Edin), FRCS(Glasg) is a member of the following medical societies: All India Ophthalmological Society and American Academy of Ophthalmology

Disclosure: Nothing to disclose.

Coauthor(s)

Gangaprasad Muthaiah Amula, MBBS, DNB  Fellow, Sankara Nethralaya Hospital, India

Disclosure: Nothing to disclose.

Specialty Editor Board

Edsel Ing, MD, FRCSC  Associate Professor, Department of Ophthalmology and Vision Sciences, University of Toronto Faculty of Medicine; Consulting Staff, Toronto East General Hospital, Canada

Edsel Ing, MD, FRCSC is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Society of Ophthalmic Plastic and Reconstructive Surgery, Canadian Ophthalmological Society, North American Neuro-Ophthalmology Society, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD  Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

Brian R Younge, MD  Professor of Ophthalmology, Mayo Clinic School of Medicine

Brian R Younge, MD is a member of the following medical societies: American Medical Association, American Ophthalmological Society, and North American Neuro-Ophthalmology Society

Disclosure: Nothing to disclose.

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Tielsch JM, Javitt JC, Coleman A, et al. The prevalence of blindness and visual impairment among nursing home residents in Baltimore. N Engl J Med. May 4 1995;332(18):1205-9. [Medline].

  2. Munoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol. Jun 2000;118(6):819-25. [Medline].

  3. Albert DM, Jakobeic FA. Optic atrophy. In: Principles and Practice of Ophthalmology. 2nd ed. Philadelphia: WB Saunders; 2000:4108- 4113.

  4. Anderson DR. Ascending and descending optic atrophy produced experimentally in squirrel monkeys. Am J Ophthalmol. Nov 1973;76(5):693-711. [Medline].

  5. Glaser JS. Neuro-Ophthalmology. 2nd ed. Philadelphia: JB Lippincott; 1990:115–117.

  6. Hoyt WF, Schlicke B, Eckelhoff RJ. Fundoscopic appearance of a nerve-fibre-bundle defect. Br J Ophthalmol. Aug 1972;56(8):577-83. [Medline].

  7. Kline LB, Bajandas FJ. Neuro-ophthalmology Review Manual. 5th ed. New Jersey: Slack; 2004:153-164.

  8. Kline LB, ed. Optic nerve disorders. In: Ophthalmology Monographs. Vol 10. San Francisco, Calif: American Academy of Ophthalmology; 1996.

  9. Kuppersmith MJ, Krohn D. Cupping of the optic disc with compressive lesions of the anterior visual pathway. Ann Ophthalmol. 1984;16:948–953.

  10. Miller NR, Newman NJ. Walsh & Hoyt's Clinical Neuro-ophthalmology. 6th ed. Philadelphia: JB Lippincott; 208- 218.

  11. Miller NR, Newman SA. Transsynaptic degeneration. Arch Ophthalmol. Sep 1981;99(9):1654. [Medline].

  12. Newman NJ. Optic disc pallor: a false localizing sign. Surv Ophthalmol. Jan-Feb 1993;37(4):273-82. [Medline].

  13. Patel DA, Hove MW. Focal Points. Vol XXIV. No 2. San Francisco, Calif: American Academy of Ophthalmology; March 2006.

  14. Schwartz B. Cupping and pallor of the optic disc. Arch Ophthalmol. Apr 1973;89(4):272-7. [Medline].

  15. Tasman W, Jaeger EA. Topical diagnosis of optic nerve lesions. In: Duane's Ophthalmology. Philadelphia: JB Lippincott; 2007.

  16. Thompson HS. Pupillary signs in the diagnosis of optic nerve disease. Trans Ophthalmol Soc U K. Sep 1976;96(3):377-81. [Medline].

  17. Trobe JD, Glaser JS, Cassady J, et al. Nonglaucomatous excavation of the optic disc. Arch Ophthalmol. Jun 1980;98(6):1046-50. [Medline].

  18. Trobe JD, Glaser JS, Cassady JC. Optic atrophy. Differential diagnosis by fundus observation alone. Arch Ophthalmol. Jun 1980;98(6):1040-5. [Medline].

Previous
Next
 
Normal optic nerve histopathology.
Glaucomatous optic atrophy histopathology.
Healthy optic disc.
Nonarteritic anterior ischemic optic neuropathy.
Arteritic anterior ischemic optic neuropathy, cilioretinal artery occlusion.
Primary optic atrophy.
Optic atrophy following papilledema (secondary).
Glaucomatous optic atrophy.
Juvenile open-angle glaucoma (JOAG) with optic pallor.
Consecutive optic atrophy following panretinal photocoagulation (PRP).
Table 1. Various Common Groups of Disorders Presenting with Optic Atrophy
PostneuritisIschemic



Arteritic



Ischemic



Nonarteritic



Compressive
Age15-50 yApproximately 70 ySixth decadeVaries based on cause
SexMultiple sclerosis F>MF>MF=MVaries based on cause
Visual acuityVaries from mild blurring (34%) and moderate loss of acuity (12%) to severe or total loss of light perception (complete blindness) in 54% of cases, to no light perception. The loss of vision is acute and progressive.--Vision usually recovers within 2 mo< 20/200 (6/60)>20/200 (6/60)Varies from mild blurring to no light perception
Color visionColor vision > vision lossColor vision loss = vision lossColor vision loss = vision lossColor vision = vision loss
RAPD*++++
MotilityPainful movement in cases of retrobulbar neuritisNormalNormalDepends on the site of compression
NystagmusIn multiple sclerosis, beating nystagmus (upbeating or downbeating) may be seenNoNoSee-saw nystagmus in optic chiasm compression
Optic discTemporal pallorPallid disc edemaSegmental disc edema Bow-tie pallor seen in optic chiasm compression; varies in other instances
Electrophysiologic studyVEP-increased latency <†>VEP-reduced amplitudeVEP-reduced amplitudeReduced VEP amplitude
Neuroimaging



(CT, MRI)



In multiple sclerosis, hyperechoic lesions are seen in the brain on MRI--Can delineate the exact location of compression
Other associationsHeadache, scalp tenderness, jaw claudicationHypertension and diabetesHeadache, vomiting, and focal neurologic deficits
*RAPD - Relative afferent pupil defect



<†>VEP - Visual-evoked potential



Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.